Chemicals

4-Bromotoluene

We are 4-Bromotoluene CAS:106-38-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 4-Bromotoluene

CAS.NO:106-38-7

Synonyms: 4-Bromotoluene

p-Bromotoluene

Benzene, 1-bromo-4-methyl-

1-bromo-4-methylbenzene

Molecular Formula:C7H7Br

Molecular Weight:171.03400

Physical and Chemical Properties:

Density:1.39 g/mL at 25 °C(lit.)

Boiling point:184 °C(lit.)

Melting point:26-29 °C(lit.)

Flash point:185 °F

Index of Refraction:1.549

Specification:

Appearance:Colorless or light yellow liquid

Purity:≥99.0%

Packing:25kg/drum, can also be packaged according to customer requirements

Storage:The warehouse is ventilated and dried at low temperature, and stored and transported separately from oxidants and food materials.

Application:4-Bromotoluene is used as a reagent in the preparation of aromatic diselenides which are useful for generating anticancer lead compounds.

4-Bromotoluene

Related News: GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.1,5-Naphthalene diisocyanate CAS:3173-72-6 GlaxoSmithKline’s HIV drugs division ViiV Healthcare said on Saturday that the U.S. Food and Drug Administration declined to approve its long acting HIV injection.5-formil-2,4-dimetil-1H-pirrol-3-carboxilato de etilo CAS:2199-59-9 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).366821-62-7 Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).

Product Name
2-bromo-1,1,1,2,3,3,3-heptafluoropropane Cas:422-77-5	View Details
Ethyl 3-amino-4-fluorobenzoate	View Details
(3-(9H-Carbazol-9-yl)phenyl)boronic acid	View Details